Protection by novel vaccine candidates, Mycobacterium tuberculosis ΔmosR and ΔechA7, against challenge with a Mycobacterium tuberculosis Beijing strain.
about
Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacyC-reactive protein, Neopterin and Beta2 microglobulin levels pre and post TB treatment in The GambiaRecombinant BCG Expressing LTAK63 Adjuvant induces Superior Protection against Mycobacterium tuberculosis.
P2860
Protection by novel vaccine candidates, Mycobacterium tuberculosis ΔmosR and ΔechA7, against challenge with a Mycobacterium tuberculosis Beijing strain.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Protection by novel vaccine ca ...... m tuberculosis Beijing strain.
@ast
Protection by novel vaccine ca ...... m tuberculosis Beijing strain.
@en
type
label
Protection by novel vaccine ca ...... m tuberculosis Beijing strain.
@ast
Protection by novel vaccine ca ...... m tuberculosis Beijing strain.
@en
prefLabel
Protection by novel vaccine ca ...... m tuberculosis Beijing strain.
@ast
Protection by novel vaccine ca ...... m tuberculosis Beijing strain.
@en
P2860
P1433
P1476
Protection by novel vaccine ca ...... m tuberculosis Beijing strain.
@en
P2093
Adel M Talaat
Howard Steinberg
P2860
P304
P356
10.1016/J.VACCINE.2015.08.084
P407
P50
P577
2015-09-09T00:00:00Z